Broidrick Amy S. (CIK 0001822917)

Latest company ownership

Shares held
130,000
Last filed at
Aug 4, 2022
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Jun 14, 2022 Jun 15, 2022 Qualigen Therapeutics, Inc. President Buy 91.3 +30,000 666.67% $18.6K
Apr 26, 2021 Apr 26, 2021 Qualigen Therapeutics, Inc. EVP, Chief Strategy Officer Buy 90.0 +4,500 100.00% $9.1K